Oracle Corporation (NYSE:ORCL) ranks among the best rebound stocks to buy right now. On March 13, Argus reduced its price ...
Oracle (NYSE:ORCL) was in focus on Thursday as investment firm Argus raised its earnings estimates and upgraded the IT tech giant after it reported fiscal third-quarter results. Shares were flat in ...
AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research Organization (CRO), PrimeVigilance, is significantly enhancing its service offerings with Oracle Argus. Delivering the full lifecycle of ...
Builds on Oracle's Endeavor to Provide an Integrated Pharmacovigilance Suite That Supports End-to-End Drug Safety Processes Across Clinical Development and Post-Market Surveillance As part of its ...
QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier ...
NEWARK, DE — QPS Holdings, LLC has implemented Oracle Argus, a widely used pharmacovigilance platform, in a move aimed at strengthening patient safety oversight and regulatory compliance across its ...
Argus, a financial analysis firm, has upgraded its price target for Oracle Corporation (NYSE: NYSE:ORCL) from $159.00 to $176.00 while maintaining a Buy rating on the shares. The firm highlighted ...
Contract Research Organization aims to improve data management, accuracy, and safety with Oracle's AI-powered pharmacovigilance platform AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Contract Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results